Paris, France, March 27, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, announces that its management will be attending the following upcoming investor and industry conferences: Cell & Gene Meeting on the Med – April 9-11 ; Rome, ItalyCompany Presentation by CEO Rodolphe Clerval on April 10 at 13.45 CET LSX World Congress – April 29-30 ; London, UKCEO Rodolphe Clerval attending and available for investor meetings BioEquity Europe –
The race—which courses over many of the same Basque Country roads as the Tour de France—will feature many of the Tour’s biggest names and plenty of one-day specialists.